Demystifying the Neuroprotective Role of Neuropeptides in Parkinson's Disease: A Newfangled and Eloquent Therapeutic Perspective.

导出 OA

翻译打印收藏纠错

作者： Tapan,Behl ^[1] ; Piyush,Madaan ^[1] ; Aayush,Sehgal ^[1] ; Sukhbir,Singh ^[1] ; Hafiz A,Makeen ^[2] ; Mohammed,Albratty ^[3] ; Hassan A,Alhazmi ^[4] ; Abdulkarim M,Meraya ^[2] ; Simona,Bungau ^[5]

作者单位： Chitkara College of Pharmacy, Chitkara University, Rajpura 140401, India. ^[1] Pharmacy Practice Research Unit, Department of Clinical Pharmacy, College of Pharmacy, Jazan University, Jazan 45142, Saudi Arabia. ^[2] Department of Pharmaceutical Chemistry, College of Pharmacy, Jazan University, Jazan 45142, Saudi Arabia. ^[3] Department of Pharmaceutical Chemistry, College of Pharmacy, Jazan University, Jazan 45142, Saudi Arabia.;Substance Abuse and Toxicology Research Center, Jazan University, Jazan 45142, Saudi Arabia. ^[4] Department of Pharmacy, Faculty of Medicine and Pharmacy, University of Oradea, 410028 Oradea, Romania.;Doctoral School of Biomedical Sciences, University of Oradea, 410028 Oradea, Romania. ^[5]

关键词 Parkinson’s disease ghrelin neuropeptide Y neuropeptides neuroprotective action neurotensin pituitary adenylate cyclase-activating polypeptide substance P

主题词人类(Humans);炎症(Inflammation);神经肽类(Neuropeptides);神经保护药(Neuroprotective Agents);帕金森病(Parkinson Disease);垂体腺苷酸环化酶激活多肽(Pituitary Adenylate Cyclase-Activating Polypeptide)

DOI 10.3390/ijms23094565

PMID 35562956

发布时间 2024-08-27

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交